Published in Lancet on May 13, 1989
Hepatitis A. BMJ (1991) 3.77
Clinical trial with inactivated hepatitis A vaccine and recommendations for its use. BMJ (1992) 2.76
Nucleotide sequence of wild-type hepatitis A virus GBM in comparison with two cell culture-adapted variants. J Virol (1994) 1.80
Attenuated hepatitis A virus: genetic determinants of adaptation to growth in MRC-5 cells. J Virol (1994) 1.28
The hepatitis A virus polyprotein expressed by a recombinant vaccinia virus undergoes proteolytic processing and assembly into viruslike particles. J Virol (1991) 1.00
Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A. J Clin Invest (1992) 0.88
Prevalence of hepatitis A antibody among disadvantaged gypsy children in northern Spain. Epidemiol Infect (1995) 0.84
Exposure to enteroviruses and hepatitis A virus among divers in environmental waters in France, first biological and serological survey of a controlled cohort. Epidemiol Infect (1994) 0.82
Innate and adaptive immune responses against picornaviruses and their counteractions: An overview. World J Virol (2012) 0.78
Immune response to hepatitis A virus capsid proteins after infection. J Clin Microbiol (1996) 0.78
Hepatitis A vaccination. West J Med (1993) 0.76
Liver disease. Postgrad Med J (1994) 0.76
Hepatitis A vaccine. Lancet (1989) 0.75
Hepatology. Postgrad Med J (1991) 0.75
Antihypertensive beta blocking action as related to renin and age: a pharmacologic tool to identify pathogenetic mechanisms in essential hypertension. Am J Cardiol (1975) 2.00
International application of a new probability algorithm for the diagnosis of coronary artery disease. Am J Cardiol (1989) 1.77
Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS) J Am Coll Cardiol (1990) 1.76
A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multicenter Trial of Angioplasty for Shock-(S)MASH. Eur Heart J (1999) 1.66
Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy. Eur Heart J (1996) 1.52
Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial. Br Heart J (1992) 1.50
Lack of progress in cardiogenic shock: lessons from the GUSTO trials. Eur Heart J (2000) 1.50
The use of B-type natriuretic peptide in the management of elderly patients with acute dyspnoea. J Intern Med (2005) 1.46
Substantial intraindividual variability of BNP concentrations in patients with hypertension. J Hum Hypertens (2006) 1.46
Differences of disease progression in congestive heart failure due to alcoholic as compared to idiopathic dilated cardiomyopathy. Eur Heart J (1996) 1.44
Exercise-induced ST depression and ST/heart rate index to predict triple-vessel or left main coronary disease: a multicenter analysis. J Am Coll Cardiol (1992) 1.42
Predictors of long-term mortality and cardiac events in patients with known or suspected coronary artery disease who survive major non-cardiac surgery. Anaesthesia (2005) 1.42
Long-term follow-up of patients with silent ischemia during exercise radionuclide angiography. J Am Coll Cardiol (1990) 1.40
The inverse Nehb J lead increases the sensitivity of Holter electrocardiographic monitoring for detecting myocardial ischemia. Am J Cardiol (1997) 1.39
Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events. Am Heart J (2006) 1.24
[Consensus for the identification of geriatric patients in the emergency care setting in Germany]. Z Gerontol Geriatr (2012) 1.20
Acid stability of hepatitis A virus. J Gen Virol (1989) 1.18
Prospects for a hepatitis A virus vaccine. Prog Med Virol (1990) 1.12
Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation (1994) 1.08
Transcatheter closure of atrial septal defect and patent foramen ovale with ASDOS device (a multi-institutional European trial). Am J Cardiol (1998) 1.08
Safe use of platelet GP IIb/IIIa inhibitors. Eur Heart J (1998) 1.07
Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy. Circulation (2001) 1.07
Safe use of platelet GP IIb/IIIa inhibitors. Am Heart J (1998) 1.04
Cardiogenic shock complicating acute myocardial infarction: predictors of death. GUSTO Investigators. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries. Am Heart J (1999) 1.02
Heart valve replacement with St. Jude Medical valve prosthesis. Long-term experience in 743 patients in Switzerland. Circulation (1988) 0.99
Response of left ventricular volume to exercise in man assessed by radionuclide equilibrium angiography. Circulation (1979) 0.98
Combined acebutolol/nifedipine therapy in patients with chronic coronary artery disease: additional improvement of ischemia-induced left ventricular dysfunction. Am J Cardiol (1982) 0.96
Left ventricular volumes by gated equilibrium radionuclide angiography: a new method. Circulation (1979) 0.94
Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol (2000) 0.94
Arterial vasodilator, systemic and coronary hemodynamic effects of nisoldipine in congestive heart failure secondary to ischemic or dilated cardiomyopathy. Am J Cardiol (1987) 0.91
Closed-loop stimulation using intracardiac impedance as a sensor principle: correlation of right ventricular dP/dtmax and intracardiac impedance during dobutamine stress test. Pacing Clin Electrophysiol (2000) 0.89
Aortic valve replacement in elderly patients with aortic stenosis. Br Heart J (1994) 0.88
Properties of a hepatitis A virus candidate vaccine strain. J Gen Virol (1987) 0.88
Long-term prognosis of young patients after myocardial infarction in the thrombolytic era. Clin Cardiol (1997) 0.87
Influence of n-6 and n-3 polyunsaturated fatty acids on the resistance to experimental tuberculosis. Metabolism (1997) 0.87
Important differences between short- and long-term hemodynamic effects of amiodarone in patients with chronic ischemic heart disease at rest and during ischemia-induced left ventricular dysfunction. J Am Coll Cardiol (1985) 0.85
ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007. Eur Heart J (2008) 0.85
Comparative effects of nitroglycerin, nifedipine and metoprolol on regional left ventricular function in patients with one-vessel coronary disease. Circulation (1983) 0.85
Virus capping on mycoplasma cells and its effect on membrane structure. Biochim Biophys Acta (1982) 0.85
Effects of the beta-adrenoceptor-blocking agent Sotalol on ventricular arrhythmias in patients with chronic ischemic heart disease. A placebo-controlled, double-blind cross-over study. Cardiology (1983) 0.85
Improvement of exercise-induced left ventricular dysfunction with oral propranolol in patients with coronary heart disease. Am J Cardiol (1979) 0.85
Comparison of 99mTc-sestamibi lung/heart ratio, transient ischaemic dilation and perfusion defect size for the identification of severe and extensive coronary artery disease. Eur J Nucl Med (2001) 0.85
Influence of dietary (n-3)-polyunsaturated fatty acids on leukotriene B4 and prostaglandin E2 synthesis and course of experimental tuberculosis in guinea pigs. Infection (1994) 0.84
Emergency valve replacement for active infective endocarditis. J Cardiovasc Surg (Torino) (1989) 0.84
Immunogenicity of a hepatitis A virus vaccine. J Med Virol (1987) 0.84
Prevalence and significance of reversible radionuclide ischemic perfusion defects in symptomatic aortic valve disease patients with or without concomitant coronary disease. Am Heart J (1982) 0.84
Simultaneous vaccination for hepatitis A and B. J Infect Dis (1990) 0.83
Improved myocardial ischemia detection by combined physical and mental stress testing. Am J Cardiol (1998) 0.83
Accuracy of serial myocardial perfusion scintigraphy with thallium-201 for prediction of graft patency early and late after coronary artery bypass surgery. A controlled prospective study. Circulation (1982) 0.82
Clinical evaluation of the St. Jude Medical heart valve prosthesis. A two-year follow-up of 150 patients. J Thorac Cardiovasc Surg (1984) 0.82
Palliative care for the geriatric patient in Europe. Survey describing the services, policies, legislation, and associations. Z Gerontol Geriatr (2010) 0.81
VDD(R) pacing: short- and long-term stability of atrial sensing with a single lead system. Pacing Clin Electrophysiol (1996) 0.81
Influence of different background and left-ventricular assignments on the ejection fraction in equilibrium radionuclide angiography. Radiology (1980) 0.81
Altered surface structure of Acholeplasma laidlawii induced by mycoplasmavirus L3 infection. Eur J Cell Biol (1981) 0.80
Coronary artery spasms after coronary artery bypass surgery. Anesthesiology (1984) 0.80
Effects of bisoprolol in relation to metoprolol and bufuralol on left ventricular hemodynamics at rest and during exercise in chronic ischemic heart disease. J Cardiovasc Pharmacol (1986) 0.79
Predictors of loss of atrioventricular synchrony in single lead VDD pacing. Heart (1998) 0.79
Left ventricular ejection fraction changes during recovery from treadmill exercise: a preliminary report of a new method for detecting coronary artery disease. Clin Cardiol (1980) 0.79
[Physical exercise in old age]. Z Gerontol Geriatr (2005) 0.79
Regional wall motion assessment in stress echocardiography by tissue Doppler bull's-eyes. J Am Soc Echocardiogr (1999) 0.78
The effect of diaphragmatic attenuation on 201Tl images. Clin Nucl Med (1979) 0.78
Immune response to hepatitis A virus capsid proteins after infection. J Clin Microbiol (1996) 0.78
Algorithm to predict triple-vessel/left main coronary artery disease in patients without myocardial infarction. An international cross validation. Circulation (1991) 0.78
Safety and efficacy of abciximab combined with dalteparin in treatment of acute coronary syndromes. Eur Heart J (2002) 0.78
Aprotinin in aortocoronary bypass surgery: increased risk of vein-graft occlusion and myocardial infarction? Supportive evidence from a retrospective study. Thromb Haemost (1996) 0.78
Acute hemodynamic effects of bufuralol: a beta-adrenoceptor blocking drug with vasodilatory effects. J Cardiovasc Pharmacol (1984) 0.78
Assessment of early ventricular systole by first pass radionuclide angiography: useful method for detection of left ventricular dysfunction at rest in patients with coronary artery disease. Am J Cardiol (1979) 0.78
Selection bias of elderly patients with chronic angina referred for catheterization. Int J Cardiol (2005) 0.78
Profiles of radionuclide left ventricular ejection fraction changes induced by supine bicycle exercise in normals and patients with coronary heart disease. Cathet Cardiovasc Diagn (1979) 0.78
Reproducibility of ejection fraction and ventricular volume by gated radionuclide angiography after myocardial infarction. Radiology (1979) 0.78
[Hemodynamic effects of a combination of general and peridural anesthesia during anesthesia induction in geriatric patients]. Anaesthesist (1991) 0.77
Noninvasive stress testing of myocardial ischemia: comparison of GRE-MRI perfusion and wall motion analysis to 99 mTc-MIBI-SPECT, relation to coronary angiography. Eur Radiol (1997) 0.77
Chest pain early after percutaneous coronary intervention: incidence and relation to ECG changes, cardiac enzymes and follow-up events. J Invasive Cardiol (2001) 0.77
Multiple coronary arteriocameral fistulas as a cause of myocardial ischemia. Am Heart J (1988) 0.76
Prognostic impact of systemic inflammatory diseases in elderly patients with congestive heart failure. QJM (2013) 0.76
Repressive coping in geriatric patients' reports - impact on fear of falling. Z Gerontol Geriatr (2008) 0.76
Improved two-year outcomes after drug-eluting versus bare-metal stent implantation in women and men with large coronary arteries: importance of vessel size. Int J Cardiol (2013) 0.75
Why do we have different urinary catheter use in European home care? Age Ageing (2005) 0.75
Non-invasive grading of aortic regurgitation by Doppler ultrasonography. Br Heart J (1986) 0.75
[Pharmacokinetic studies of a new 20% fat emulsion containing 70% medium-chain triglycerides]. Anasth Intensivther Notfallmed (1990) 0.75
Acute hemodynamic effects of MDL 19205 in mild congestive heart failure. J Cardiovasc Pharmacol (1987) 0.75
[Clinical presentation and diagnosis of coronary heart disease]. Schweiz Rundsch Med Prax (1990) 0.75
[The long-term management of heart transplant patients]. Ther Umsch (1990) 0.75
[Functional control of vena cava filters using duplex sonography]. Vasa Suppl (1989) 0.75
[Emergency coronary dilatation in acute myocardial infarct with contraindications to thrombolytic therapy: salvage of the myocardium by early intervention]. Schweiz Rundsch Med Prax (1989) 0.75
[Nalbuphine and piritramid in the postoperative phase in young children. 1. General condition]. Anaesthesist (1990) 0.75
[Physical performance with rate-responsive pacemakers]. Schweiz Med Wochenschr (1986) 0.75
Direct vascular and myocardial effects of nisoldipine. Am J Cardiol (1990) 0.75
[Thrombocyte inhibitors in cardiovascular therapy]. Schweiz Rundsch Med Prax (1990) 0.75
Cardiac evaluation of candidates for kidney transplantation: value of exercise radionuclide angiocardiography. Eur Heart J (1990) 0.75